Karl A. Knutsson
Via Olgettina 60
Milan, 20132, Italy
Milan, 20132, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Long-Term Graft Survival Following Penetrating Keratoplasty in Eyes with Preoperative Corneal Neovascularization.
Journal: Ophthalmology and therapy
Published: May 27, 2026
A Multicenter, Real-World Experience with Polyhexamethylene Biguanide (PHMB) 0.08% Monotherapy for Treating Acanthamoeba Keratitis: A Retrospective Review of 39 Cases.
Journal: Ophthalmology and therapy
Published: March 16, 2026
Validation of a Regression Formula to Predict Post-DMEK Keratometry and Improve IOL Power Calculation in Eyes Undergoing Phacoemulsification Combined With DMEK.
Journal: Journal of refractive surgery (Thorofare, N.J. : 1995)
Published: March 07, 2026
Acanthamoeba keratitis treatment outcomes compared for drug delivery by protocol versus physician's individualised treatment.
Journal: The ocular surface
Published: November 24, 2024
Treatment of Acanthamoeba keratitis with high dose PHMB (0.08%) monotherapy in clinical practice: A case series.
Journal: European journal of ophthalmology
Published: November 14, 2024
Unusual presentation of ocular surface squamous neoplasia in a young healthy patient: A case report.
Unusual presentation of ocular surface squamous neoplasia in a young healthy patient: A case report.
Journal: European journal of ophthalmology
Published: May 23, 2024
Corneal descemetocele following Nd:YAG laser capsulotomy in a patient with Steven Johnson syndrome: A case report.
Journal: American journal of ophthalmology case reports
Published: November 13, 2023
Beauveria bassiana Keratitis: A Case Series and Review of Literature.
Journal: Journal of clinical medicine
Published: October 22, 2023
Photo Quiz: Therapeutic Contact Lens-Associated Fungal Keratitis.
Journal: Journal of clinical microbiology
Published: July 20, 2023
The Orphan Drug for Acanthamoeba Keratitis (ODAK) Trial: PHMB 0.08% (Polihexanide) and Placebo versus PHMB 0.02% and Propamidine 0.1.
Journal: Ophthalmology
Published: June 16, 2023
Last Updated: 09/26/2026